Pregled bibliografske jedinice broj: 134269
Antiviral antibodies reduce the cytomegalovirus infection of the brain
Antiviral antibodies reduce the cytomegalovirus infection of the brain // American journal of reproductive immunology, 46 (2001), 1; 57-57 (podatak o recenziji nije dostupan, kongresno priopcenje, znanstveni)
CROSBI ID: 134269 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Antiviral antibodies reduce the cytomegalovirus infection of the brain
Autori
Golemac, Mijo ; Čičin-Šain, Luka ; Bralić, Marina ; Tomac, Jelena ; Pernjak Pugel, Ester ; Britt, J. William ; Jonjić, Stipan
Izvornik
American journal of reproductive immunology (1600-0897) 46
(2001), 1;
57-57
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kongresno priopcenje, znanstveni
Ključne riječi
MCMV ; protutijela ; mozak
(MCMV ; antibodies ; brain)
Sažetak
PROBLEM: Congenital cytomegalovirus (CMV) infection is among the leading causes of brain disease in infants and the most common non-familial cause of hearing loss in developed countries. Small animal models in adult hosts have recapitulated many of the features of human CMV infection with the exception of brain infection. We have established a model of murine CMV (MCMV) brain infection in newborn mice. We used this model to study the feasibility of antiviral antibodies as a therapy means of CMV infection of the brain. METHOD OF STUDY: Newborn mice have been infected intraperitonealy (IP) with various doses of MCMV. Anti-CMV antisera were IP inoculated at different time points following infection and mice were sacrificed on days 7, 11, 14 and 21 after infection. Control mice received the same amount of non-immune sera or no serum at all. The viral presence in the brain has been analysed by plaque assay on murine embrional fibroblasts and immunohistochemistry. RESULTS: Mice treated with antisera consistently showed lower virus titres as compared to control mice. Consistently with that the histological examination showed reduced local inflammatory changes in mice treated with anti-CMV sera. CONCLUSION: Our results indicate that antiviral antibodies can both prevent the CMV spread to the brain and reduce the infection upon it has been established in the brain. Thus, passive antibody transfer to the host may prove as a valuable therapeutics in the congenital CMV infection.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
062005
Ustanove:
Medicinski fakultet, Rijeka
Profili:
Mijo Golemac
(autor)
Ester Pernjak-Pugel
(autor)
Stipan Jonjić
(autor)
Jelena Tomac
(autor)
Luka Čičin-Šain
(autor)
Marina Bralić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- MEDLINE